Efficacy, Safety and Tolerability of Denosumab in the Treatment of Rheumatoid Arthritis

NCT00095498 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

227

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: placebo
DRUG: denosumab

Sponsor

Amgen